Evolving transactional appetites, growth of casino games real money no deposit therapy areas, emerging supply chain risks and digital transformation are only some of the many issues impacting the growth trajectories of healthcare and life sciences companies globally, while simultaneously contending with complex regulatory regimes and global, local and regional legal pressures. Stay apprised of these developments, trends and opportunities through our dedicated resources hub.
Learn more about our Global Healthcare & Life Sciences Industry Group through the five-minute video below.
Life Sciences Business Evolution Series
Intertwined value chains and digitalization are increasingly shaping the life sciences industry of the future. In this series, explore how pharmaceutical, biotechnology, medical devices and medtech companies plan to evolve their business models, shaping the future of the life sciences ecosystem. Findings are based on a survey conducted in collaboration with Informa Pharma Intelligence, featuring insights from over 250 life sciences executives in Asia Pacific, the Americas and Europe.
Explore More Resources
Chambers Life Sciences Practice Guide 2022 | Life Sciences Collaborations | |
![]() |
![]() |
|
Offers commentary on legal and business issues in major healthcare and life sciences markets | Issues to consider in executing life sciences collaborations in the COVID-19 era | |
Guide to IPOs for Biotech and Pharma Companies |
Global Guide to Patent Linkage |
|
![]() |
![]() |
|
An overview of the key considerations at each stage of the IPO process |
Legal regimes covering patent linkage doctrines and enforcement options for drug patent rights holders |
|
Global Medical Cannabis Survey |
Interacting with Healthcare Professionals |
|
![]() |
![]() |
|
An interactive global dashboard on the import and export rules in over 100 markets. Please contact Lilli Meldrum to request access. |
Regulations and traditional practices governing interactions with healthcare professionals (HCPs) |
|
Promoting Medical Products Globally |
Brexit: Key Implications for the Healthcare and Life Sciences Sector |
|
![]() |
![]() |
|
Regulations covering ethical business interactions between medical companies and healthcare professionals |
Key areas in the healthcare and life sciences sector impacted by the UK's casino games real money no deposit trading relationship with EU |
|
EMEA Digital Health Solutions |
COVID-19: A Global Review of Healthcare and Life Sciences Industry Issues |
|
![]() |
![]() |
|
Top digital health solutions and legal issues to bear in mind when contemplating a project in the digital sector |
A comparative tool that answers questions on market access, clinical trials, IP risks and telemedicine |
|
Clinical Trials Handbook |
UAE: Health Data Law |
|
![]() |
![]() |
|
Legal framework governing clinical trials of medicinal products in 34 jurisdictions |
Lists the permitted exceptions and conditions to the data transfer restrictions |
|
Healthcare MapApp 3.0 |
||
![]() |
||
Access real-time information on the laws and regulations in more than 50 countries |
|
|
Healthcare & Life Sciences Supply Chain Series
Focuses on the trends, issues and opportunities along each stage of the supply chain life cycle

FT Big Deal Series: The Healthtech Sector’s Spectacular Surge in SPACs and de-SPACS
A 3-minute video chat on the rise of SPAC investments in the healthtech sector
Biden Supply Chain Policy Video Series: Episode 5 - Pharmaceuticals and Active Pharmaceutical Ingredients
Discusses the impact of the Biden Administration's policies on FDA regulations and government procurement
LSX Masterclass: Partnering & Licensing
Explores how biotech companies can navigate licensing issues and find the right fit for the future
Global Healthcare & Life Sciences Webinar Series
Aims to share legal industry insights and provide practical guidance
The Health Pod
Looks at sector-specific issues and trends
Connect on Tech Podcast Series
Episode 15: Inside the Global Battle for Healthcare Data
Discusses the regulatory restrictions and M&A considerations when protecting healthcare data
Episode 18: Telehealth and COVID-19: US Privacy Changes and Considerations
Updates to US regulations and enforcement priorities that have evolved in response to the pandemic
3R Podcast Series
Episode 10: The Acceleration of Innovation in Healthcare: The Rise of Digital Health Services
Discusses the roles of the government and corporates in fostering innovation in healthcare
TMT Talk
Episode 9: Digital Transformation: Analysis Using the SMART Framework
casino games real money no deposit s on technology hot topics such as healthtech
Visit casino games real money no deposit Plus for our latest legal updates covering healthcare and life sciences developments across the globe
Learn more about the important considerations at each stage of the supply chain life cycle for healthcare and life sciences companies, including issues which may arise in the areas of M&A, tax, compliance, trade secrets, digital transformation and ESG.
Sustainability Solutions for the Healthcare and Life Sciences Industries
Identifies the key areas driving the shift in sustainability priorities in the sector
Features our extensive experience in the complex world of products regulated by the FDA, including drugs, medical devices, food, cosmetics, and dietary supplements
Showcases our multidisciplinary offerings to support clients entering, maintaining and expanding their operations within this fast-growing industry
